| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.017 | 0.6 |